Feed SOLV
SO

Solventum

SOLV · NYSE

$88.86 +0.02% (+$0.02)
1M -2.64%
Market Cap $15.4B
P/E Ratio 10.73x
Div. Yield -
ROE 28.96%
Piotroski F-Score Strong
7/9
Valuation
90 /100
Cheap
P/B 3.21x
P/S 1.85x
P/E 10.73x
Growth
28 /100
Declining
Rev. growth 0.79%
Book val. growth 24.52%
EPS growth 4.46%
Profitability
69 /100
Strong
FCF margin 1.42%
Op. margin 24.99%
Gross margin 54.69%
Quality
84 /100
Excellent
Asset turnover 0.58x
ROA 10.07%
ROIC 15.85%
Debt
57 /100
Moderate
Net debt/EBITDA 1.88x
Int. coverage 7.38x
Debt/Equity 1.10x
Stability
67 /100
Stable
Profitable years 4
EPS volatility 150.17%
Beta 0.69x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SOLV
Online

O podjetju

Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Bryan C. Hanson

Employees

20,584

Headquarters

Eagan

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

44d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.